Pages that link to "Q35977382"
Jump to navigation
Jump to search
The following pages link to A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group (Q35977382):
Displaying 26 items.
- Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter? (Q28069761) (← links)
- Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer (Q28396304) (← links)
- Drug penetration in solid tumours (Q29614404) (← links)
- Targeting multidrug resistance in cancer (Q29616803) (← links)
- Tumour stem cells and drug resistance (Q29617742) (← links)
- Development of multidrug-resistance convertors: sense or nonsense? (Q33180943) (← links)
- Chemotherapy for brain metastases of lung cancer: a review (Q33724545) (← links)
- The Role of ABC Transporters in Clinical Practice (Q34268081) (← links)
- Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas (Q36115974) (← links)
- Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma (Q36291680) (← links)
- Implications of cancer stem cells in the treatment of cancer (Q36677482) (← links)
- Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor (Q36788463) (← links)
- Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? (Q38055067) (← links)
- Future perspectives for the development of P-glycoprotein modulators (Q40271710) (← links)
- Clinical Studies with Modulators of Multidrug Resistance (Q40464085) (← links)
- Historical, current and future aspects of osteosarcoma treatment (Q40830532) (← links)
- A survey of the ethical considerations in randomised trials for lung cancer (Q40854948) (← links)
- Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in p‐glycoprotein‐expressing MCF7 human breast adenocarcinoma cells (Q41320426) (← links)
- Influence of metabolites on protein binding of verapamil enantiomers (Q43201881) (← links)
- Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin. (Q44199622) (← links)
- EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation (Q44235598) (← links)
- Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response (Q46109720) (← links)
- Intestinal P-glycoprotein inhibitors, benzoxanthone analogues (Q48120399) (← links)
- Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice. (Q54171304) (← links)
- Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma (Q73356015) (← links)
- [Expression of multidrug resistance (MDR)-associated proteins in solid tumors] (Q83924636) (← links)